Dr. Plante obtained her medical degree from Laval University in 1985 and completed her residency in obstetrics and gynecology at McGill University in 1990. She continued with a 3-year subspecialty in gynecologic oncology at the Memorial Sloan-Kettering Cancer Center in New York in 1993. Since then, she has worked as a gynecologist-oncologist at l’Hôtel-Dieu de Québec.
Dr. Plante is a Professor in the Department of Obstetrics and Gynecology at Laval University. She is head of the oncology-gynecology department and in charge of clinical research at l’Hôtel-Dieu de Québec.
- Plante is best known for her expertise in minimally invasive surgery in the treatment of gynecological cancers, including robot-assisted surgery, the sentinel lymph node technique in gynecological cancers and in surgeries aimed at preserving fertility in young women suffering from cervical cancer, including radical trachelectomy.
- Plante is the principal investigator of a large international, prospective and randomized study led by the Canadian Cancer Trials Group (CCTG) and the Gynecologic Cancer InterGroup (GCIG) (CX-5 or SHAPE study). The study aims to randomize patients with early-stage and low-risk cervical cancer to receive either radical hysterectomy (standard) or simple hysterectomy (studied). More than 700 patients will be randomized in this study.
- In addition, Dr. Plante is particularly interested in oncogenetics related to ovarian cancer. She has been involved in the activities of the oncogenetics department, along with the St-Sacrement Hospital team, since its inception, and is responsible for its ovarian component.
- Co-chair of CCRN (Cervical Cancer Research Network)
- Chair, International Committee, SGO (Society of Gynecologic Oncology)
- Co-chair, Cervix Working Group, CCTG
- Member, Editorial Board, International Journal of Gynecologic Cancer (IJGC) and Journal of Obstetrics and Gynecology of Canada (JOGC)
11, côte du Palais
Canada G1R 2J6
Data not available
Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.Journal Article
Gynecol Oncol, 2018, ISSN: 0090-8258.
Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).Journal Article
Int J Gynecol Pathol, 37 (3), pp. 205-228, 2018, ISSN: 0277-1691.
Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery.Journal Article
J Steroid Biochem Mol Biol, 178 , pp. 45-54, 2018, ISSN: 0960-0760.
The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.Journal Article
Gynecol Oncol, 148 (3), pp. 485-490, 2018, ISSN: 0090-8258.
Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women.Journal Article
Front Endocrinol (Lausanne), 9 , pp. 87, 2018.
- Centre de recherche sur le cancer, Subvention, Institutionnel - BDR, BDR - Centres de recherche reconnus, from 1996-05-01 to 2023-04-30
- Centre hospitalier universitaire de Québec - CHU de Québec-Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
- Randomized trial comparing radical hysterectomy and pelvic node dissection vs simple hysterectomy and pelvic node dissection in patients with low risk cervical cancer defined as lesions measuring less than 2 cm with less than 50% stromal in, Subvention, Instituts de recherche en santé du Canada, Subvention de fonctionnement, from 2012-03-31 to 2020-03-31
Recently finished projects
- Soutien d'un projet de recherche clinique en gynéco-oncologie, Subvention, Fondation du CHU de Québec, from 2016-03-14 to 2017-03-13